Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis

Journal of Clinical Laboratory Analysis

Volumn 19, Issue 4, 2005, Pages 172-176

  Erdener, Dilek ^a   Aksu, Kenan ^a   Biçer, Ilhan ^a   Doǧanavşargil, Eker ^a   Kutay, Fatma Z ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Lupus nephritis: rheumatoid arthritis; N acetyl d glucosaminidase; Proteinuria

Indexed keywords

N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNE DISEASE; BIOCHEMISTRY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; EARLY DIAGNOSIS; FEMALE; HUMAN; KIDNEY TUBULE EPITHELIUM; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROSIS; PREDICTION; PROTEIN URINE LEVEL; PROTEINURIA; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME; URINARY EXCRETION; WORLD HEALTH ORGANIZATION;

ACETYLGLUCOSAMINIDASE; ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED;

EID: 23044441949     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20073     Document Type: Article

References (24)

1. Price RG. The role of NAG (N-acetyl-β-D-glucosaminidase) in the diagnosis of kidney disease, including the monitoring of nephrotoxicity. Clin Nephrol 1992;38:14-19.
2. Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998;7:604-610.
3. Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus 1998;7:635-638.
4. Alba P, Bento L, Cuadrado MJ, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-559.
5. Myllykangas-Luosujärvi RA, Aho K, Isomäki Ha. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193-202.
6. Bazzi C, Petrini C, Rizza V, et al. Urinary N-acetyl-β- glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-1896.
7. Bosomworth MP, Aparicio SR, Hay AWM. Urine N-acetyl-β-D- glucosaminidase-a marker of tubular damage? Nephrol Dial Transplant 1999;14:620-626.
8. Tan EM, Cohen AS, Freis JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1277.
9. Golbus J, McCune WJ. Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment. Rheum Dis Clin North Am 1994;20:213-242.
10. Kashgarian M. New approaches to clinical pathologic correlation in lupus nephritis. Am J Kidney Dis 1982;2:164-169.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-328.
12. Werner M, Maruhn D, Atoba M. Use of gel filtration in the assay of urinary enzymes. J Chromatog 1969;40:254-263.
13. Maruhn D. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 1976;73:453-461.
14. Berden JHM. Lupus nephritis. Kidney Int 1997;52:538-558.
15. Boumpas DT, Balow JE. Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998;7:622-629.
16. Austin HA. Clinical evaluation and monitoring of lupus kidney disease. Lupus 1998;7:618-621.
17. Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM. Response to treatment as a predictor of longterm outcome patients with lupus nephritis. J Rheumatol 1994;21:2052-2057.
18. D'Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren's syndrome, and rheumatoid arthritis. In: Jennette JCH, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's pathology of the kidney. Philadelphia: Lippincott-Raven; 1998. p 541-624.
19. Hultberg B, Ravnskov U. The excretion of N-acetyl-β-D- glucosaminidase in glomerulonephritis. Clin Nephrol 1981;15:33-38.
20. Burton CJ, Walls J. Proximal tubular cell, proteinuria and tubulointerstitial scarring. Nephron 1994;68:287-293.
21. Falaschi F, Ravelli A, Martignoni A, et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2000;43:1405-1409.
22. Hultberg B. Urinary excretion of β-hexosaminidase in different forms of proteinuria. Clin Chim Acta 1980;108:195-199.
23. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE disease activity index. Lupus 1999;8:462-465.
24. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-872.